Skip to main content
SP5007,785.76-0.17%DOW53,732.41-0.20%NASDAQ26,729.16-0.28%BTC$62,945.00-0.85%ETH$1,880.32-0.35%GOLD$4,432.00+0.26%OIL$82.40+1.42%
Smart Investors Daily
Sign InSign Up Free
WX

OTC · WXXWY

WuXi Biologics (Cayman) Inc.

Healthcare · Biotechnology

$11.88

Up+$0.32 (+2.77%)

Updated Aug 16, 2026, 9:54 PM

SID Score

5.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
17.21B
P/E ratio
30.57
Dividend yield
0.00%
52-week range
— – —
Volume
3.99K
Avg. volume
37.66K

Price performance

WXXWY price history

1M range · 0 trading sessions · Daily adjusted prices

WXXWY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest WXXWY news

The latest Smart Investors Daily articles mentioning WXXWY.

Stock researchCompany · Overview

WXXWY research

Overview

Company profile and research snapshot.

Company profile

WUXI BIOLOGICS UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$10.10
Implied upside
—
Analysts
33
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 29, 2026

WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMO

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has been included in the FTSE4Good Index Series in recognition of its outstanding sustainability performance, marking the sixth consecutive year the company has received this distinction. The inclusion further underscores WuXi Biologics' long-term leadership in Environmental, Social and Governance (ESG) and highlights the Company's ability to consistently cre

Yahoo · Jan 16, 2026

Is WuXi Biologics (SEHK:2269) Still Attractively Priced After Its 121% One Year Rebound

If you are wondering whether WuXi Biologics (Cayman) is still attractively priced after its rebound, you are not alone. This article breaks down what the current share price might be implying about value. The stock last closed at HK$39.78, with returns of 7.3% over the past week, 22.2% over the past month, 22.2% year to date and 121.5% over the past year, while the 3-year and 5-year returns stand at 44.2% and 67.2% declines respectively. Recent coverage has focused on WuXi Biologics (Cayman)...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By